New asthma treatment threatens inhaler companies – In-PharmaTechnologist.com

New asthma treatment threatens inhaler companies
In-PharmaTechnologist.com
A new oral medication for asthma sufferers could wipe out half of all business for inhaler manufacturers. Researchers, lead by Respiratory Research's Professor David Price, completed a two-year long pragmatic trial into

View full post on asthma – Google News

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.